D Mulleman
Overview
Explore the profile of D Mulleman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jean M, Irisson J, Gras G, Bouchand F, Simo D, Duran C, et al.
Scand J Rheumatol
. 2016 Apr;
46(1):64-68.
PMID: 27098514
Objectives: Pyogenic vertebral osteomyelitis (PVO) is a rare disease with possible severe complications (e.g. sepsis and spinal cord injury). In the 1990s, diagnostic delay (DD) was often extensive as PVO...
2.
Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, et al.
Clin Exp Immunol
. 2015 May;
181(3):385-400.
PMID: 25959571
Biopharmaceuticals (BPs) represent a rapidly growing class of approved and investigational drug therapies that is contributing significantly to advancing treatment in multiple disease areas, including inflammatory and autoimmune diseases, genetic...
3.
Chevalier X, Ravaud P, Maheu E, Baron G, Rialland A, Vergnaud P, et al.
Ann Rheum Dis
. 2014 May;
74(9):1697-705.
PMID: 24817417
Aim: To test the efficiency of tumour necrosis factor blockers (adalimumab) in patients with painful refractory (non-responders to analgesics and non-steroidal anti-inflammatory drugs (NSAIDs)) hand osteoarthritis (OA). Methods: We performed...
4.
Mulleman D, Thibault G
Arthritis Rheumatol
. 2014 Apr;
66(4):1054-5.
PMID: 24757157
No abstract available.
5.
Gras G, Buzele R, Parienti J, Debiais F, Dinh A, Dupon M, et al.
Eur J Clin Microbiol Infect Dis
. 2013 Sep;
33(3):371-5.
PMID: 24057139
The purpose of this investigation was to evaluate the microbiological diagnosis yield of post-biopsy blood cultures (PBBCs) and second percutaneous needle biopsy (PNB) following an initial negative biopsy in vertebral...
6.
Melet J, Mulleman D, Goupille P, Ribourtout B, Watier H, Thibault G
Arthritis Rheum
. 2013 Aug;
65(11):2783-90.
PMID: 23918413
Objective: Rituximab, a monoclonal antibody specifically targeting CD20, induces B cell depletion and is effective in the treatment of rheumatoid arthritis (RA). This study was undertaken to evaluate whether routine...
7.
Henrotin Y, Chevalier X, Deberg M, Balblanc J, Richette P, Mulleman D, et al.
J Orthop Res
. 2013 Feb;
31(6):901-7.
PMID: 23423846
To measure the evolution of the serum levels of specific Osteoarthritis (OA) biomarker, Coll2-1 and Coll2-1 NO₂ in knee osteoarthritic patients after viscosupplementation (VS). Fifty-one patients with unilateral symptomatic knee...
8.
Chu Miow Lin D, Mulleman D, Azzopardi N, Griffoul-Espitalier I, Valat J, Paintaud G, et al.
Scand J Rheumatol
. 2010 Feb;
39(1):97-8.
PMID: 20132079
No abstract available.
9.
Tiffreau V, Mulleman D, Coudeyre E, Lefevre-Colau M, Revel M, Rannou F
Ann Readapt Med Phys
. 2007 Oct;
50(9):741-6, 734-40.
PMID: 17963971
Objective: To develop clinical practice guidelines concerning individual and group exercise therapy for knee and/or hip osteoarthritis (OA). Method: We used the SOFMER (French Physical Medicine and Rehabilitation Society) methodology,...
10.
Belot V, Mulleman D, Perrinaud A, Abdallah-Lotf M, Machet M, Machet L
Ann Dermatol Venereol
. 2007 Oct;
134(8-9):673-7.
PMID: 17925693
Background: Eosinophilic fasciitis (Shulman syndrome) is defined by the association of sclerodermatous skin changes involving underlying fascia and hypereosinophilia. While the aetiology is unknown, some observations suggest an infectious origin....